Email
Print
Cardiac Assist Devices Market - Forecast(2024 - 2030)
Cardiac Assist Devices Market Overview
Cardiac assist devices market size was valued at $1,307 million in 2020 and is anticipated to grow at a CAGR of 8.2% during the forecast period 2021-2026. The cardiac assist devices industry growth rate is attributed to the increasing focus on the growing demand for efficient cardiac assist devices in developed countries, along with an increase in the prevalence of heart failure which is poised in bringing new opportunities. Cardiac Assist Devices (CADs) are blood pumps that support the circulatory functions of severely ill cardiac patients. CADs are usually implanted in patients with acute heart failure, for example after myocardial infarction or after surgery. Furthermore, patients awaiting a heart transplant, whose cardiac function deteriorates before a suitable organ can be implanted, need circulatory support for the period before a transplant. In selected patients with dilative cardiomyopathy, a CAD might be removed after a prolonged support period, and when the patient’s own heart has recovered and can maintain blood circulation. Moreover, adoptions of cardiac assist devices over the study period coupled with the emergence of state-of-the-art healthcare technologies have fueled the uptake of minimally invasive surgery for faster and better outcomes. However, the comparatively high prices of the ventricular assist devices (VADs) for advanced heart failure coupled with expensive follow-up care are poised to hinder the Cardiac Assist Devices market.
Report Coverage
The report: “Cardiac Assist Devices Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Cardiac Assist Devices Market:
By Product Type: Ventricular Assist Device, Total Artificial Heart, Intra-Aortic Balloon Pump and Others.
By Modality: Transcutaneous, Implantable.
By Application: Bridge-to-transplant (BTT) Therapy, Destination Therapy, Bridge-to-recovery (BTR) Therapy, Bridge-to-candidacy (BTC) Therapy and Others.
By Distribution Channel: Hospital, Ambulatory Surgical Centers and Others.
By Geography: North America (U.S, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Others), APAC (China, Japan, India, South Korea, Australia and Others), South America(Brazil, Argentina and Others) and RoW (Middle East and Africa).
Key Takeaways
- The factors such as rising adoption of innovative various cardiac assist devices owing to rise in the incidence of heart failures and several patients with cardiovascular diseases (CVDs) such as myocardial infarction are amongst the major factor projected to impel growth of cardiac assist devices market.
- Additionally, factors such as rising government funding for product development and ongoing research activities are to create opportunities paving a way for the growth in the market during the forecast period 2021-2026.
Cardiac Assist Devices Market Segment Analysis - By End Users, 2020(%)
For More Details on This Report - Request for Sample
Cardiac Assist Devices Market Segment Analysis - By Modality
In 2020, on the basis of modality, implantable segment accounted for the largest segmental revenue of the Cardiac Assist Devices market. The implantable held the largest market on account of the fact that this modality type ventricular assist devices has shown a surge in the usage owing to an increase in the number of several myocardial infarction cases globally. Also, the segment is to hold its dominance through the forecast period 2021-2026 with a healthy growth in CAGR of 8.69% as this segment is visualizing the entry of numerous market players specifically focused into the innovation of new products hence; broadening the scope of application is also poised to hold the market share.
Cardiac Assist Devices Market Segment Analysis - By End Users
On the basis of end users, hospital segment accounted for the largest segmental revenue of the cardiac assist value market in 2020. The large share can be attributed to the high adoption of cardiac assist devices among hospitals, owing to the emergence of the COVID-19 pandemic coupled with the increase in the number of several cardiovascular diseases cases such as myocardial infarction globally are also to boost the adoption of such devices in hospitals, and this will accelerate the growth of the hospital segment in the CADs market during the forecast period 2021-2026.
On the other hand, ambulatory care centers segment is projected to dominate over the forecast period 2021-2026 with a CAGR of 8.50%. The ambulatory care centers are to witness a healthy growth owing to the fact that the pandemic has had quite a significant effect on the CAD’s sales market; owing to the rising percentage of total transcutaneous surgical procedures occurring in free-standing ASCs which has had a significant impact on inpatient management, necessitating a dedicated workforce, patient isolation, and strict visiting hour policies which is to promote the growth. Apart from this, outpatient visits have been restricted to minimize interaction between patients and hospital staff, with significant implications for pre-operative care quality and the human side of medicine which is also anticipated to offer significant growth for the ambulatory care centers segments during the forecast period 2021-2026.
Cardiac Assist Devices Market Segment Analysis - By Geography
North America is the major region dominating the cardiac assist devices market with a market share of 37.90% in the year 2020. This can be attributed to the fact that the rise in demand for cardiac assist devices sales is increasing owing to the availability of advanced features such as connectivity with Bluetooth and smart countdown. Furthermore, the presence of well-established reimbursement policies and increasing awareness pertaining to ventricular assist devices such as bridge-to-transplant, destination therapies, etc. are boosting the cardiac assist devices market share, which further fuels the regional market.
However, Asia-Pacific is projected to be the significant-growing market during the forecast period 2021-2026 as several countries such as India and China has rising expenses on healthcare followed by a vast set of untapped opportunities in the regional markets such as the “Make in India” campaign and increasing public and private investments which is poised to propel the market growth throughout the cardiac assist devices market forecast period 2021-2026. Moreover, in Asia-Pacific countries there is rising geriatric population in countries that are poised to result in a surge in several myocardial infarction cases thereby, augmenting the regional market growth.
Cardiac Assist Devices Market Drivers
Rapid Adoption Of Cardiac Assist Devices
The cardiac assist devices market is poised to receive upswing demand owing to the rapid increase in demand for several cardiac assist devices and attributed to the fact that these kits are equipped with several cutting-edge innovations, such as a smart countdown and Bluetooth connectivity that has resulted in all major pharmaceutical companies focusing on such innovative formulation technologies. Moreover, there is also a rise in the number of incidence of patients with heart failures such as myocardial infarction over the globe thereby, leaving them with little time to seek medical help hence, there is a rising use of cardiac assist devices and is to propel the market growth over the forecast period 2021-2026.
Cardiac Assist Devices Market Challenges
High Price Of Cardiac Assist Devices
One of the major factors lowering the cardiac assist devices is owing to the fact that advanced cardiac assist devices are sold at higher prices coupled with expensive follow-up care which is hindering the market growth during the forecast period 2021-2026. Moreover, these cardiac assist devices also pose certain risks for implantation procedures such as infection, blood clotting, problems with device, etc. which is also acting as a challenge across the globe.
Cardiac Assist Devices Market Landscape
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Cardiac Assist Devices market. In 2020, Cardiac Assist Devices market share is fragmented by the top ten players present in the market. The Cardiac Assist Devices market top 10 companies are Calon Cardio-Technology Ltd., MAQUET GmbH & Co., Biophan Technologies, Berlin Heart GmbH, Teleflex Incorporated, Heart Ware International, Bioheart, Abiomed Inc., Thoratec Corporation, SynCardia Systems and others.
Acquisitions/Product Launches
- In October 2019, Abbott received FDA approval for the HeartMate 3 left ventricular assist device (LVAD) as destination therapy for advanced heart failure patients who are ineligible for a transplant.
- In May 2019, Abiomed launched the Impella CP commercially with SmartAssist at the 2019 Society for Cardiovascular Angiography & Interventions (SCAI).
Relevant Reports:
Report Code: HCR 0421
Report Code: HCR 0032
For more Lifesciences and Healthcare Market reports, please click here
1. Cardiac Assist Devices Market - Overview
1.1 Definitions and Scope
2. Cardiac Assist Devices Market - Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Product Type
2.3 Key trends by Application
2.4 Key trends by Geography
3. Cardiac Assist Devices Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. Cardiac Assist Devices Market - Startup Companies Scenario Premium
4.1 Key Startup Company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Venture Capital and Funding Scenario
5. Cardiac Assist Devices Market – Industry Market Entry Scenario Premium Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case Studies of Successful Ventures
6. Cardiac Assist Devices Market Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porters five force model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Cardiac Assist Devices Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. Cardiac Assist Devices Market - By Product Type (Market Size –$Million/$Billion)
8.1 Ventricular Assist Device (VAD)
8.1.1 Left Ventricular Assist Device (LVAD)
8.1.2 Right Ventricular Assist Device (RVAD)
8.1.3 Biventricular assist device (BIVAD)
8.1.4 External Ventricular Assist Devices
8.2 Intra-aortic Balloon Pump
8.3 Total Artificial Heart
8.4 Others
9. Cardiac Assist Devices Market - By Modality (Market Size –$Million/$Billion)
9.1 Transcutaneous
9.2 Implantable
10. Cardiac Assist Devices Market - By Application (Market Size –$Million/$Billion)
10.1 Bridge-to-transplant (BTT) Therapy
10.2 Destination Therapy
10.3 Bridge-to-recovery (BTR) Therapy
10.4 Bridge-to-candidacy (BTC) Therapy
10.5 Others
11. Cardiac Assist Devices Market - By End Users (Market Size –$Million/$Billion)
11.1 Hospital
11.2 Ambulatory Surgical Centers
11.3 Others
12. Cardiac Assist Devices Market - By Geography(Market Size –$Million/$Billion)
12.1 North America
12.1.1 U.S.
12.1.2 Mexico
12.1.3 Canada
12.2 Europe
12.2.1 U.K.
12.2.2 France
12.2.3 Germany
12.2.4 Russia
12.2.5 Italy
12.2.6 Spain
12.2.7 Rest of Europe
12.3 Asia Pacific
12.3.1 China
12.3.2 India
12.3.3 Japan
12.3.4 South Korea
12.3.5 Australia & New Zealand
12.3.6 Rest of APAC
12.4 South America
12.4.1 Brazil
12.4.2 Argentina
12.4.3 Others
12.5 Rest of the World
12.5.1 Middle East
12.5.2 Africa
12.5.3 South America
13. Cardiac Assist Devices Market - Entropy
14. Cardiac Assist Devices Market – Industry/Segment Competition Landscape Premium
14.1 Market Share Analysis
14.1.1 Global Market Share – Key Companies
14.1.2 Market Share by Region – Key companies
14.1.3 Market Share by Countries – Key Companies
14.1.4 Best Practices for Companies
15. Cardiac Assist Devices Market – Key Company List by Country Premium Premium
16. Cardiac Assist Devices Market Company Analysis
16.1 Company 1
16.2 Company 2
16.3 Company 3
16.4 Company 4
16.5 Company 5
16.6 Company 6
16.7 Company 7
16.8 Company 8
16.9 Company 9
16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.